This legislation directs the Comptroller General of the United States to undertake a comprehensive study within 18 months of enactment, focusing on the use and effects of remote monitoring for individuals who are prescribed opioids. The findings of this study will be compiled into a detailed report and submitted to relevant committees in both the House and Senate. The report must include an assessment of scientific evidence regarding the efficacy, individual outcomes, and potential cost savings associated with remote monitoring, comparing monitored and unmonitored individuals. It will also evaluate the current prevalence of remote monitoring, including international practices. Furthermore, the report is tasked with providing recommendations to enhance the availability, access, and coverage of remote monitoring, specifically considering changes to Federal health care programs and identifying specific cohorts who would most benefit from this technology.